Fluticasone/salm 115/21mcg Inh 120s

Manufacturer PRASCO LABORATORIES Active Ingredient Fluticasone and Salmeterol Inhaler(floo TIK a sone & sal ME te role) Pronunciation floo TIK a sone & sal ME te role
It is used to treat asthma.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
đŸˇī¸
Drug Class
Bronchodilator/Corticosteroid Combination
đŸ§Ŧ
Pharmacologic Class
Inhaled Corticosteroid (ICS) / Long-Acting Beta2-Adrenergic Agonist (LABA)
🤰
Pregnancy Category
Category C
✅
FDA Approved
Aug 2000
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medicine is an inhaler that contains two different drugs: one is a steroid (fluticasone) that helps reduce swelling and inflammation in your lungs, and the other (salmeterol) is a long-acting bronchodilator that helps open up your airways, making it easier to breathe. It's used regularly, usually twice a day, to prevent asthma attacks or manage COPD symptoms, but it's not for sudden breathing problems.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only.

Key Instructions:

Use this medication as directed by your doctor or healthcare provider, even if you feel well.
Take your dose at the same time every day.
After each use, rinse your mouth with water and spit it out - do not swallow the rinse water.
If you are using multiple inhaled medications, ask your doctor which one to use first.
Before using the inhaler, shake it well.
Before the first use, prime the inhaler by spraying 4 test sprays into the air, away from your face. If the inhaler has not been used for more than 4 weeks or has been dropped, prime it again with 2 sprays into the air, away from your face, shaking well before each test spray.
Replace the cap after each use.

Important Safety Precautions:

This medication is flammable, so do not use it near an open flame or while smoking.
Some inhalers have a dose counter to track the number of doses remaining. If your inhaler has a dose counter, discard it when the counter reaches "0".

Storage and Disposal:

Store the medication at room temperature in a dry place, away from the bathroom.
Store the inhaler with the mouthpiece down.

Missed Dose:

If you miss a dose, skip it and return to your regular schedule.
* Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Use the inhaler regularly as prescribed, even if you feel well. Do not stop suddenly.
  • This is a maintenance medication, not a rescue inhaler. Always carry your short-acting rescue inhaler (e.g., albuterol) for sudden breathing problems.
  • Rinse your mouth with water and spit it out after each dose to help prevent oral thrush (a fungal infection in the mouth) and hoarseness.
  • Do not exceed the prescribed dose or use more often than every 12 hours.
  • Keep track of your symptoms and peak flow readings (if applicable) and report any worsening to your doctor.
  • Avoid triggers that worsen your asthma/COPD (e.g., smoke, allergens, pollution).
  • Maintain good hydration and a healthy lifestyle.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 1 inhalation (Fluticasone 115 mcg / Salmeterol 21 mcg) twice daily, approximately 12 hours apart
Dose Range: 115 - 115 mg

Condition-Specific Dosing:

Asthma: 1 inhalation (Fluticasone 115 mcg / Salmeterol 21 mcg) twice daily
COPD: Not indicated for COPD at this strength; higher strengths (250/50 or 500/50) are typically used for COPD.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for this strength (115/21 mcg). Lower strengths (e.g., 100/50 mcg or 250/50 mcg for older children/adolescents) are used for asthma.
Adolescent: For asthma in adolescents â‰Ĩ12 years: 1 inhalation (Fluticasone 115 mcg / Salmeterol 21 mcg) twice daily, approximately 12 hours apart.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment recommended
Moderate: No dosage adjustment recommended
Severe: No dosage adjustment recommended
Dialysis: No specific recommendations; systemic exposure is low.

Hepatic Impairment:

Mild: No dosage adjustment recommended
Moderate: Use with caution; monitor for systemic corticosteroid effects and salmeterol adverse effects.
Severe: Use with caution; monitor for systemic corticosteroid effects and salmeterol adverse effects. Increased systemic exposure to fluticasone propionate and salmeterol may occur.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It reduces inflammation in the airways, decreasing bronchial hyperreactivity and mucus production. Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA) that selectively stimulates beta2-adrenergic receptors in the lungs, leading to relaxation of bronchial smooth muscle and bronchodilation. The combination provides both anti-inflammatory and bronchodilator effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: <30% (oral), ~10-30% (inhaled); Salmeterol: Low systemic bioavailability due to extensive first-pass metabolism.
Tmax: Fluticasone: 0.5-1 hour (inhaled); Salmeterol: 5-10 minutes (inhaled)
FoodEffect: Not applicable for inhaled administration.

Distribution:

Vd: Fluticasone: ~318 L; Salmeterol: ~1500-2000 L
ProteinBinding: Fluticasone: ~91%; Salmeterol: ~96%
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: ~7.8 hours (terminal); Salmeterol: ~5.5 hours (terminal)
Clearance: Fluticasone: ~1150 mL/min; Salmeterol: ~1000 mL/min
ExcretionRoute: Fluticasone: Feces (primarily); Salmeterol: Feces (primarily), Urine (minor)
Unchanged: Fluticasone: <5% (urine); Salmeterol: <1% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes (significant bronchodilation); Fluticasone: Days to weeks for full anti-inflammatory effect.
PeakEffect: Salmeterol: 2-4 hours; Fluticasone: 1-2 weeks for maximal therapeutic benefit.
DurationOfAction: Salmeterol: 12 hours; Fluticasone: Dose-dependent, sustained anti-inflammatory effect.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial (SMART study) showed an increased risk of asthma-related deaths in patients receiving salmeterol. This finding is considered a class effect of LABAs. Therefore, Fluticasone/Salmeterol should only be used in patients with asthma as concomitant therapy with an inhaled corticosteroid. It is not indicated for the primary treatment of asthma.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, extreme dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or excitable
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat

Important Warning: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek immediate medical attention.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor:

Headache
Upset stomach or vomiting
Throat irritation
* Common cold symptoms

This list is not exhaustive. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening breathing problems or asthma attacks despite using the medication regularly.
  • Increased need for your rescue inhaler.
  • Chest pain, fast or irregular heartbeat, or severe palpitations.
  • Severe tremor or nervousness.
  • Signs of infection in your mouth or throat (white patches).
  • Blurred vision, eye pain, or seeing halos around lights (potential signs of glaucoma/cataracts).
  • Signs of a serious allergic reaction (rash, hives, swelling of face/lips/tongue, difficulty breathing/swallowing).
  • Unusual tiredness, weight loss, nausea, vomiting, or dizziness (signs of adrenal insufficiency, especially if stopping steroids suddenly).
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any medications you are taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, that may interact with this medication. Certain medications used to treat conditions like HIV, infections, and depression may not be compatible with this drug. Your doctor or pharmacist can advise you on potential interactions.
Please note that this is not an exhaustive list of all medications or health conditions that may interact with this drug.

To ensure your safety, it is crucial to discuss the following with your doctor and pharmacist:

All medications you are currently taking, including prescription and OTC drugs, natural products, and vitamins.
Any health problems you have, as they may affect the safety of taking this medication.

Remember to always check with your doctor before starting, stopping, or changing the dose of any medication to ensure safe use and minimize potential interactions.
âš ī¸

Precautions & Cautions

Important Information About Your Medication

Inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. It may take approximately 1 week to experience the full effects of this drug.

Diabetes Warning
If you have high blood sugar (diabetes), consult with your doctor, as this medication may increase your blood sugar levels.

Respiratory Problems
If your breathing problems worsen, your rescue inhaler is less effective, or you need to use it more frequently, contact your doctor immediately.

Dosage and Administration
Do not exceed the recommended dose or use this medication more often than prescribed. Overdose can be fatal. Consult with your doctor if you have any concerns.

Transitioning from Oral Steroids
When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Monitor for signs such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these symptoms.

Stressful Situations
In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in these situations.

Long-term Use
Prolonged use of this medication may increase the risk of developing cataracts or glaucoma. Consult with your doctor and schedule regular eye exams as recommended.

Osteoporosis Risk
Long-term use may also lead to weak bones (osteoporosis). Discuss your risk factors with your doctor and undergo bone density tests as advised.

Infection Risk
You may be more susceptible to infections while taking this medication. Practice good hygiene by washing your hands frequently, and avoid close contact with individuals who have infections, colds, or flu.

Viral Infections
If you have not had chickenpox or measles before, avoid exposure to these viruses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed, consult with your doctor.

Age-Related Precautions
If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

Pediatric Use
This medication may affect growth in children and teenagers. Regular growth checks may be necessary. Consult with your doctor to discuss potential risks and benefits.

Pregnancy and Breastfeeding
Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Your doctor will help you weigh the benefits and risks of this medication for you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Salmeterol overdose: Tachycardia, palpitations, tremor, headache, nausea, dizziness, hypokalemia, hyperglycemia, hypertension, arrhythmias, chest pain.
  • Fluticasone overdose: Acute overdose is unlikely due to low systemic absorption. Chronic overdose may lead to signs of hypercorticism (e.g., Cushing's syndrome, adrenal suppression).

What to Do:

Seek immediate medical attention or call 911. Treatment is supportive and symptomatic. Monitor cardiac function (ECG), serum potassium, and blood glucose. Consider a cardioselective beta-blocker for severe salmeterol effects, but use with extreme caution in patients with bronchospasm. For chronic fluticasone overdose, gradual withdrawal of therapy may be necessary.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, cobicistat) due to increased systemic exposure to fluticasone and salmeterol, leading to increased risk of cardiovascular events (e.g., QTc prolongation, palpitations) and systemic corticosteroid effects (e.g., Cushing's syndrome, adrenal suppression).
🔴

Major Interactions

  • Other long-acting beta2-adrenergic agonists (LABAs) - increased risk of cardiovascular adverse effects.
  • Beta-blockers (especially non-selective) - may block the bronchodilatory effect of salmeterol and cause severe bronchospasm in patients with asthma/COPD.
  • Diuretics (loop or thiazide) - increased risk of hypokalemia and ECG changes, especially with high doses of salmeterol.
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs) - may potentiate the cardiovascular effects of salmeterol (e.g., QTc prolongation, arrhythmias).
🟡

Moderate Interactions

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil, grapefruit juice) - may increase systemic exposure to fluticasone and salmeterol, requiring caution and monitoring.
  • Sympathomimetics - additive cardiovascular effects.
  • Xanthine derivatives (e.g., theophylline) - increased risk of hypokalemia and arrhythmias.
đŸŸĸ

Minor Interactions

  • Not specifically identified for minor interactions with significant clinical impact.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pulmonary Function Tests (FEV1)

Rationale: To establish baseline lung function and assess disease severity (asthma/COPD).

Timing: Prior to initiation of therapy.

Asthma/COPD Control Assessment

Rationale: To establish baseline symptom frequency, severity, and impact on daily life.

Timing: Prior to initiation of therapy.

Adrenal Function (e.g., morning cortisol)

Rationale: Consider for patients transitioning from systemic corticosteroids or at high risk for adrenal suppression.

Timing: Prior to initiation, if indicated.

Electrolytes (Potassium)

Rationale: To establish baseline, especially if patient is on diuretics or has risk factors for hypokalemia.

Timing: Prior to initiation, if indicated.

📊

Routine Monitoring

Pulmonary Function Tests (FEV1)

Frequency: Periodically (e.g., every 3-12 months or as clinically indicated)

Target: Improvement from baseline, maintenance of optimal lung function.

Action Threshold: Worsening FEV1 despite adherence, indicating inadequate control or disease progression.

Asthma/COPD Symptom Control

Frequency: Regularly (e.g., at each follow-up visit, patient self-monitoring daily)

Target: Minimal symptoms, infrequent rescue inhaler use, no nocturnal awakenings.

Action Threshold: Increased symptom frequency/severity, increased rescue inhaler use, nocturnal symptoms, exacerbations.

Growth (Pediatric Patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age.

Action Threshold: Growth retardation, requiring re-evaluation of therapy.

Oral Cavity Inspection

Frequency: At each visit

Target: Absence of oral candidiasis.

Action Threshold: Presence of white patches, requiring antifungal treatment and proper rinsing technique review.

Bone Mineral Density (BMD)

Frequency: Periodically, especially for long-term high-dose use or risk factors for osteoporosis.

Target: Stable BMD.

Action Threshold: Significant bone loss, requiring intervention and re-evaluation of therapy.

Ocular Examination (for cataracts/glaucoma)

Frequency: Annually, especially for long-term high-dose use or risk factors.

Target: Normal intraocular pressure, absence of cataracts.

Action Threshold: Increased intraocular pressure, development of cataracts, requiring ophthalmology referral.

Electrolytes (Potassium)

Frequency: Periodically, if patient is at risk for hypokalemia (e.g., on diuretics, severe disease).

Target: Normal serum potassium levels.

Action Threshold: Hypokalemia, requiring supplementation or re-evaluation of therapy.

đŸ‘ī¸

Symptom Monitoring

  • Worsening asthma/COPD symptoms (e.g., increased shortness of breath, wheezing, cough, chest tightness)
  • Increased need for rescue inhaler (short-acting beta-agonist)
  • Oral candidiasis (thrush) - white patches in mouth/throat
  • Hoarseness or dysphonia
  • Palpitations or rapid heart rate
  • Tremor
  • Nervousness or anxiety
  • Muscle cramps
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain, fatigue, weakness)
  • Blurred vision or eye pain (potential glaucoma/cataracts)

Special Patient Groups

🤰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnant women. Animal studies have shown teratogenic effects with high doses of fluticasone and salmeterol. Uncontrolled asthma poses a greater risk to both mother and fetus than the potential risks of the medication.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity, though systemic exposure is low. Risk vs. benefit should be carefully weighed.
Second Trimester: Generally considered safer than first trimester, but continued monitoring for maternal and fetal well-being.
Third Trimester: Risk of preterm labor or low birth weight if asthma is uncontrolled. Monitor for potential effects on fetal adrenal function (though unlikely with inhaled doses).
🤱

Lactation

Caution should be exercised when Fluticasone/Salmeterol is administered to a nursing woman. It is unknown if fluticasone or salmeterol are excreted in human milk. However, other corticosteroids and beta2-agonists are excreted. The benefits of breastfeeding should be weighed against the potential risks to the infant.

Infant Risk: Low systemic exposure in the mother suggests low levels in breast milk, but potential for adverse effects on the infant (e.g., growth suppression, adrenal suppression, cardiovascular effects) cannot be entirely ruled out. Monitor the infant for adverse effects.
đŸ‘ļ

Pediatric Use

Not indicated for children under 4 years of age. For children 4-11 years, lower strengths (e.g., 100/50 mcg) are typically used for asthma. For adolescents â‰Ĩ12 years, the 115/21 mcg strength may be used. Monitor growth velocity in pediatric patients receiving inhaled corticosteroids, as they may cause a reduction in growth rate.

👴

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, elderly patients may be more susceptible to the cardiovascular effects of salmeterol (e.g., arrhythmias, hypertension) and systemic corticosteroid effects. Use with caution and monitor for adverse reactions.

Clinical Information

💎

Clinical Pearls

  • Fluticasone/Salmeterol is a maintenance medication and should NOT be used for acute bronchospasm. Patients must have a short-acting beta-agonist (SABA) for rescue.
  • Always instruct patients to rinse their mouth thoroughly with water and spit it out after each dose to minimize the risk of oral candidiasis (thrush) and dysphonia.
  • Emphasize the importance of regular, twice-daily dosing, approximately 12 hours apart, even when symptoms are well-controlled.
  • Educate patients on the correct inhaler technique, as improper use can lead to reduced drug delivery and efficacy.
  • Due to the LABA component, a Black Box Warning exists regarding increased risk of asthma-related death. It should only be used in asthma patients as concomitant therapy with an inhaled corticosteroid.
  • Monitor for signs of systemic corticosteroid effects (e.g., adrenal suppression, bone density changes, cataracts, glaucoma) with long-term, high-dose use.
  • Patients should be advised not to stop therapy abruptly, especially if they have been on high doses, due to the risk of adrenal insufficiency.
🔄

Alternative Therapies

  • Inhaled Corticosteroid (ICS) monotherapy (e.g., fluticasone propionate, budesonide, mometasone) for asthma not requiring LABA.
  • Long-Acting Muscarinic Antagonist (LAMA) monotherapy (e.g., tiotropium) for COPD.
  • Oral corticosteroids (for severe exacerbations or refractory disease).
  • Leukotriene receptor antagonists (e.g., montelukast).
  • Immunomodulators (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma.
💰

Cost & Coverage

Average Cost: $200 - $400 per inhaler (120 actuations)
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (often preferred brand or generic equivalent)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it is a good idea to consult with your pharmacist. If you have any questions or concerns about this medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.